Nitrous oxide (N 2 O) gas is a widely used anesthetic adjunct in dentistry and medicine that is also commonly abused. Studies have shown that N 2 O alters the function of the N-methyl-Daspartate (NMDA), GABA A , opioid, and serotonin receptors among others. However, the receptors systems underlying the abuserelated central nervous system effects of N 2 O are unclear. The present study explores the receptor systems responsible for producing the discriminative stimulus effects of N 2 O. B6SJLF1/J male mice trained to discriminate 10 minutes of exposure to 60% N 2 O 1 40% oxygen versus 100% oxygen served as subjects. Both the high-affinity NMDA receptor channel blocker (1) 
Introduction
Nitrous oxide gas (N 2 O), a widely used anesthetic adjunct in dentistry and surgical anesthesia, is subject to widespread abuse (Garland et al., 2009) , with as many as 88,000 people aged 12-17 years annually initiating nonmedical recreational use (http://oas. samhsa.gov/2k9/inhalantTrends/inhalantTrends.htm). The National Survey on Drug Use and Health estimated in 2005 that 21% of adolescent inhalant abusers first experience using an inhalant was with N 2 O (http://oas.samhsa.gov/2k9/inhalantTrends/inhalantTrends.htm). At the present time, the neurotransmitter system or systems responsible for the subjective intoxication produced by N 2 O are not well understood (Zacny et al., 1994; Beckman et al., 2006) , which significantly hampers the development of interventions to treat and prevent N 2 O abuse.
In vitro and in vivo experiments have shown that N 2 O modulates the activity of a number of neurotransmitter receptors. A significant body of evidence implicates the N-methyl-D-aspartate (NMDA) receptor complex as an important mediator of N 2 O's effects. N 2 O inhibits human NR1A and NR2A NMDA receptor subunits in Xenopus oocytes (Yamakura and Harris, 2000; Ogata et al., 2006) . The locomotor incoordinating effects of N 2 O are reduced in Caenorhabditis elegans, with a nmr-1 gene lossof-function mutation encoding a NMDA-type glutamate receptor (Nagele et al., 2004) . NMDA receptors in rat hippocampal neurons are inhibited in a noncompetitive and voltage-dependent manner by N 2 O (Jevtovi c-Todovori c et al., 1998; Mennerick et al., 1998) , and NMDA-evoked striatal dopamine release is reduced by N 2 O (Balon et al., 2003) . Finally, N 2 O alters isoflurane (Petrenko et al., 2010) and sevoflurane (Sato et al., 2005) minimal alveolar concentration in NMDA receptor epsilon-1 subunit gene knockout in mice.
Considerable evidence also implicates GABA A receptors as a mediator of N 2 O's effects. N 2 O potentiates GABA A receptor current in the presence of an agonist, suggesting it may act as a positive allosteric modulator (Hapfelmeier et al., 2000) . N 2 O exposure increases the current flow in GABA A a 1 b 2 g 2S and a 1 b 2 g 2L receptors expressed in Xenopus oocytes (Hapfelmeier et al., 2000; Yamakura and Harris, 2000) . N 2 O also potentiates the effects of the GABA A agonist muscimol in cultured hippocampal neurons (Dzoljic and Van Duijn, 1998) . In mice, the benzodiazepine site antagonist flumazenil and the GABA A competitive antagonist, SR-95531 [6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide], reverse the anxiolytic-like effects of N 2 O (Czech and Green, 1992; Czech and Quock, 1993; Li and Quock, 2001) . Finally, flumazenil reduces ratings of subjective "high" produced by N 2 O in human subjects (Zacny et al., 1995) .
Opioid receptors have been implicated as being involved in the analgesic and antinociceptive properties of N 2 O. The k-opioid antagonist nor-binaltorphimine but not the d-opioid antagonist naltrindole attenuates N 2 O analgesia (Koyama and Fukuda, 2010) . A mixed agonist/antagonist at m-opioid receptors, b-chlornaltrexamine reverses N 2 O antinociceptive responses (Emmanouil et al., 2008) . However, in humans naloxone does not alter N 2 O's subjective or cognitive impairing effects nor N 2 O-induced changes in pain perception (Zacny et al., 1994 (Zacny et al., , 1999 . Lastly, N 2 O results in release of serotonin in the rat spinal cord (Mukaida et al., 2007) , and other data suggest that the anxiolytic and antinociceptive effects of N 2 O may involve a serotonergic mechanism (Mueller and Quock, 1992; Emmanouil, et al., 2006) .
Taken together these studies suggest that the pharmacologic properties of N 2 O are complex and that different receptor systems may be involved depending on the response that is being examined. It is presently unclear which, if any, of these receptor systems are responsible for the abuse-related subjective effects of N 2 O. We sought to address that question by use of the drug-discrimination procedure in mice. Drug discrimination models human subjective intoxication and is an extremely powerful behavioral research tool for examining the receptor mechanisms underlying abuse-related behavioral effects of drugs (Colpaert, 1999) . We have previously demonstrated that 10 minutes of exposure to 60% N 2 O can be trained as a discriminative stimulus in mice (Richardson and Shelton, 2014) . Our data showed that N 2 O shares discriminative stimulus effects with toluene, but there is little overlap between the discriminative stimulus effects of N 2 O and other abused inhalants and vapor anesthetics. In the present study, we examined the role of NMDA, GABA A , opioid, and serotonin receptors in transducing the discriminative stimulus effects of N 2 O.
Materials and Methods
Subjects. Twenty-four adult male B6SJLF1/J mice (The Jackson Laboratory, Bar Harbor, ME) served as subjects. These mice had previously been used in a study designed to determine whether it was possible to train a discrimination based on inhaled N 2 O (Richardson and Shelton 2014) . The mice were maintained at 85% of their free-feed body weights by regulating food intake to 2-5 g of standard rodent chow per day (Harlan, Teklad, Madison, WI) after training. Water was available ad libitum except during experimental sessions. All subjects were individually housed in 31.5 cm Â 19.5 cm clear polycarbonate cages with corncob bedding (Teklad, Madison, WI) on a 12-hour light/dark cycle (lights on 6:00 AM) in a colony room maintained at 77°F with 44% humidity. Studies were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University and conducted in accordance with the Institute of Laboratory Animal Research Guide for the Care and Use of Laboratory Animals (National Research Council, 2011) .
Apparatus. Exposures to oxygen and N 2 O/oxygen gas mixtures were conducted in one of four 26-l acrylic exposure cubicles that encased modified two-lever mouse operant conditioning chambers (model ENV-307AW; MED Associates, St. Albans, VT). Two yellow light-emitting diode stimulus lights, two response levers, and a liquid dipper were located on the front wall of each chamber. A single 5-watt light-emitting diode house light was located at the top center of the chamber rear wall. The drug-discrimination schedule conditions and data recordings were controlled by a MED Associates interface and MED-PC version 4 software (MED Associates). The milk solution used as a reinforcer consisted of 25% sugar, 25% nonfat powdered milk, and 50% tap water by volume.
N 2 O and oxygen exposure mixtures were controlled by a manually operated gas metering system. Briefly, an Airsep Onyx1 oxygen concentrator (Buffalo, NY) generated $98% oxygen. N 2 O gas was supplied by a compressed N 2 O cylinder and a single-stage regulator. The N 2 O and O 2 flow rates were regulated by individual rotameters, and the individual gas streams were combined before passing into the inhalant exposure chamber. System components were connected with Tygon tubing (Fisher Scientific, Hampton, NH). Waste gas was expelled into a fume hood. The vehicle for SNC-80 was 0.9% saline, pH adjusted to between 6.0 and 7.0. L-701,324 was solubilized in 10% Cremophor in sterile water. All other injected compounds were prepared in 0.9% sterile saline. All drugs except ethanol were prepared to achieve a constant injection volume of 10 ml/kg. To prevent tissue damage, ethanol doses higher than 1000 mg/kg were produced by increasing injection volumes of a 100-mg/ml ethanol solution. Morphine sulfate was administered subcutaneously. All other injected compounds were administered intraperitoneally. SNC-80, memantine, muscimol, gaboxadol, CGS 19755, L-701,324 , and U50-488H were administered 30 minutes before testing. The mCPP was administered 20 minutes before testing. All other injected drugs were administered 10 minutes before testing. N 2 O exposures were begun 10 minutes before the start of and continued for the duration of the operant test session. All drug doses are expressed as their salt weight.
Training, Acquisition, and Substitution Test Procedure. Subjects were previously trained to discriminate a 10-minute exposure to 60% N 2 O 1 40% O 2 mixture from 100% O 2 in once daily (Monday-Friday) milk-reinforced 5-minute operant sessions (Richardson and Shelton, 2014) . In our present study, training sessions continued on Monday, Wednesday, and Thursday. Substitution test sessions were conducted each Tuesday and Friday. Briefly, the first 10 minutes of each training session was a time-out in which the animals were placed into the operant chambers and gas delivery was initiated. After 10 minutes of exposure, the house and lever lights were illuminated, and a 5-minute operant session commenced.
During the operant session, completion of a fixed-ratio 12 (FR12) response requirement on the active lever resulted in 3 seconds of access to a 0.01-ml milk dipper. Responding on the inactive lever reset the FR requirement on the correct lever. N 2 O and O 2 vehicle training sessions were presented in a double alternation sequence across training days. Subjects were eligible to test if they maintained NMDA Channel Blocker-Like Stimulus Effects of Nitrous Oxide accurate stimulus control on training sessions between tests. Specifically, the subject must have emitted their first complete FR12 on the correct lever and a minimum 80% of total lever presses on the correct lever in all of the training sessions since the last test session. If an animal failed to maintain this level of performance, the double alternation training schedule was continued until the subject met the daily accuracy criteria for three consecutive days.
On test days, both levers were active, and completion of the FR12 requirement on either lever was reinforced. Generally, substitution concentration-effect or dose-effect curves were examined in ascending dose order and were preceded by 100% O 2 and 60% N 2 O 1 40% O 2 control test sessions. When the test drug was an injected compound, both the O 2 and N 2 O control test exposures were preceded by vehicle injections. When possible, doses were increased until maximal substitution was apparent or a test condition resulted in a greater than 50% mean suppression of responding compared with the O 2 control.
Data Collection and Analysis. The dependent measures collected were the percentage of N 2 O lever responding (6 S.E.M.), the operant response rate (6 S.E.M.), and the lever upon which the first fixed ratio was completed. Mean N 2 O-lever appropriate responding of less than 20% was defined as no substitution, 21%-79% as partial substitution, and 80%-100% as full substitution. Suppression of operant responding produced by each drug was examined by one-way repeated measures analysis of variance (ANOVA) using GeisserGreenhouse corrections for sphericity. Significant main effects were followed by Dunnett post hoc tests comparing each dose to its vehicle control. Statistical analysis examining percentage N 2 O-lever selection CGS-19755 (n = 8) [n], and L-701,324 (n = 7) [e] in mice trained to discriminate N 2 O from oxygen. Points above O 2 and N 2 O reflect the 100% oxygen and 60% N 2 O + 40% oxygen control conditions. Numbers in brackets indicates the number of subjects that earned at least one reinforcer (first value) and the total number of subjects tested at that dose (second value). Filled symbols in the lower panel indicate statistically significant (P , 0.05) suppression of response rates relative to the oxygen control condition.
resulting from combining N 2 O with MK-801, ethanol, and midazolam was by two-way repeated measures ANOVA.
To accommodate missing data due to the failure of some subjects at high-dose combinations to emit sufficient responses to generate a leverselection value, each curve combining a single dose of pretreatment drug with increasing N 2 O concentrations was separately compared with the control curve combining N 2 O with vehicle. Only those dose combinations in which all subjects emitted at least one complete fixed ratio value were included in the analysis. Subsequent analyses of significant interactions were by Sidak post hoc tests.
Statistical analysis examining the response rate alterations resulting from combining N 2 O with MK-801, ethanol, and midazolam were by two-way repeated measures ANOVA comparing all N 2 O 1 drug pretreatment conditions. Subsequent analyses of significant interactions were by Sidak post hoc tests. P , 0.05 was considered statistically significant for all analyses. All ANOVA and post hoc tests were performed using Prism version 6.0 for Macintosh (GraphPad Software, San Diego, CA).
In addition, when possible, confidence limits (CL), potencies, and half-maximal effective concentrations or doses (EC 50 or ED 50 ) of the percentage of N 2 O-lever responding and suppression of operant response rates were calculated using values on the linear portion of each mean dose-effect curve using a Microsoft Excel spreadsheet (Microsoft Corporation, Redmond, WA) based on published methods (Bliss, 1967; Tallarida and Murray, 1987) .
Results
N 2 O (n 5 24) produced concentration-dependent full substitution for the 60% training concentration with an EC 50 of 33% (CL: 29%-37%) (Fig. 1, upper panel) . Control tests of 100% O 2 and 60% N 2 O 1 40% O 2 produced a mean of 2% (61) and 97% (61) N 2 O lever-selection, respectively. Full substitution was produced by both 60% and 80% N 2 O. There was a main effect of N 2 O concentration on operant responding [F (2.5,56.5) 5 15.0, P , 0.01] but only 80% N 2 O (Fig. 1, lower panel, filled symbol) significantly (P , 0.05) attenuated operant responding below the O 2 control response rates.
The high-affinity NMDA receptor channel blocker (1)-MK-801 (n 5 8) produced dose-dependent partial substitution for 60% N 2 O (Fig. 2, upper The low-affinity NMDA receptor channel blocker memantine (n 5 7) produced a maximum of 50% (610) N 2 O-lever responding at a dose of 56 mg/kg (Fig. 2, upper panel, u) . Memantine (Fig. 2 , lower panel) also dose dependently [F (2.3, 14) 5 24.16, P , 0.01] attenuated operant responding with an ED 50 of 29.2 mg/kg (CL: 24.9-34.3 mg/kg). Operant responding relative to vehicle was significantly reduced (P , 0.05) by memantine doses of 30 and 56 mg/kg (j).
The competitive NMDA antagonist CGS-19755 (n 5 8) failed to substitute for 60% N 2 O (Fig. 2, upper panel, n) . CGS-19755 (Fig. 2 , lower panel, n) attenuated operant responding [F (2.5,17.5) 5 40.8, P , 0.01] with an ED 50 of 12.0 mg/kg (CL: 8.1-17.9 mg/kg). Post hoc analysis indicated that responding was suppressed at doses of 10 and 17 mg/kg (P , 0.05, m). The NMDA receptor glycine site antagonist L-701,324 (n 5 7) also failed to substitute for N 2 O, producing no greater than 1% N 2 O-lever selection at any dose (Fig. 2,  upper panel, e) . L-701,324 (Fig. 2, lower panel, e) failed to attenuate operant responding [F (2.5,17.5) , 1, P 5 0.44] up to the maximum dose tested of 30 mg/kg. Figure 3 shows the substitution concentration-effect curves (upper panel) and response rate effects (lower panel) produced by increasing concentrations of N 2 O after pretreatment with vehicle, or 0.03 or 0.17 mg/kg (1)-MK-801 (n 5 7). The EC 50 of N 2 O 1 vehicle (Fig. 3, s) was 32% (CL: 25%-41%). Pretreatment with 0.03 mg/kg (1)-MK-801 (u) resulted in a N 2 O EC 50 of 26% (CL: 17%-39%). Pretreatment with 0.17 mg/kg (1)-MK-801 (n) produced a more pronounced 1.9-fold leftward shift in the N 2 O lever-selection curve, further reducing the EC 50 of N 2 O to 17% (CL: 13%-23%). There was no statistically significant main effect of 0.03 mg/kg (1)-MK-801 treatment [F (1,6) Table 1 shows the results of substitution testing with GABA A receptor agonists and positive modulators. Gaboxadol (n 5 8), a GABA A receptor agonist selective for d-subunit-containing extrasynaptic receptors resulted in a maximum of 4% (63) N 2 O-lever responding at a dose of 1.0 mg/kg. Gaboxadol attenuated operant responding [F (2.4,17.1) 5 105, P , 0.01] with an ED 50 of 6.4 mg/kg (CL: 2.6-15.7 mg/kg). The synaptic GABA A receptor agonist muscimol (n 5 8) produced a maximum of 22% (622) N 2 O-lever responding at a dose of 1.7 mg/kg. Muscimol dose-dependently attenuated operant response rates [F (1.5,10.4) 5 32.4, P , 0.01] with an ED 50 of 1.2 mg/kg (CL: 0.9-1.6 mg/kg).
The anticonvulsant valproic acid, which inhibits GABA transaminase, produced a maximum of 33% (615) a N 2 O-lever selection EC 50 of 25% (CL: 14%-44%). N 2 O combined with 0.3 mg/kg or 3 mg/kg midazolam produced N 2 O-lever selection EC 50 's of 35% (CL: 25%-47%) and 44% (CL: 35%-56%), respectively. There was no main effect [F (1,7) 5 1.6, P 5 0.25] or interaction [F (4,28) , 1, P 5 0.81] of 0.3 mg/kg midazolam pretreatment on N 2 O-lever selection. Analysis of variance was not performed on lever selection data generated when combining 3 mg/kg midazolam 1 N 2 O because of missing data resulting from complete suppression of responding in some subjects in the higher dose-combination conditions. There was both a main effect of midazolam pretreatment dose [F (2,14) 5 6.6, P , 0.01] as well as an interaction of midazolam pretreatment dose and N 2 O concentration [F (8,56) 5 4.5, P , 0.01] on operant rate suppression (Fig. 4, lower panel) . Post hoc analysis showed that 3 mg/kg of midazolam enhanced (P , 0.05) the response-rate suppression produced by concentrations of 20%-60% N 2 O (m). Table 2 shows the results of substitution testing with opioid receptor agonists, ethanol, and selected serotonergic agonists. The m-opioid receptor agonist morphine (n 5 8) produced a maximum of 33% (633) Figure 5 shows the effect of pretreatment with either 500 or 1500 mg/kg i.p. ethanol before exposure to increasing concentrations of N 2 O. The upper panel depicts N 2 O-lever selection and the lower panel the operant response rates. Vehicle pretreatment before N 2 O exposure (Fig. 5, upper panel, s) resulted in a N 2 O-lever selection EC 50 of 31% (CL: 27-36%). Pretreatment with a low dose of 500 mg/kg ethanol (Fig. 5 , upper panel, u) resulted in a N 2 O-lever selection EC 50 of 27% (CL: 23%-32%). Pretreatment with a higher dose of 1500 mg/kg ethanol (Fig. 5, upper panel, n) produced a 2.8-fold leftward shift in the N 2 O substitution concentration effect curve and a N 2 O-lever selection EC 50 of 11% (CL: 7%-18%).
There was no main effect [F (1,7) 5 1.5, P 5 0.3] or interaction [F (4,28) , 1, P 5 0.51] between the 500 mg/kg ethanol pretreatment dose and N 2 O concentration on the percentage N 2 O-lever selection. However, there was a main effect [F (1,7) 5 19.8, P , 0.01] as well as an interaction [F (3,21) 5 3.9, P 5 0.02] between the 1500 mg/kg ethanol pretreatment dose and N 2 O concentration on the percentage of N 2 O-lever selection. Post hoc analysis revealed that pretreatment with 1500 mg/kg ethanol enhanced (t 5 5.6, P , 0.05) the discriminative stimulus effects of 20% N 2 O (Fig. 5, upper panel, m) . There Numbers in brackets indicates the number of subjects that earned at least one reinforcer (first value) and the total number of subjects tested at that dose (second value). Filled symbols in the lower panel indicate statistically significant (P , 0.05) suppression of response rates from the corresponding N 2 O + vehicle control values.
NMDA Channel Blocker-Like Stimulus Effects of Nitrous Oxide
was a main effect of ethanol pretreatment dose [F (2,14) 5 21.1, P , 0.01] as well as an interaction [F (8,56) 5 4.1, P , 0.01] of ethanol pretreatment dose and N 2 O concentration on rates of operant responding (Fig. 5, lower panel) . Post hoc analysis revealed that 1500 mg/kg ethanol suppressed (P , 0.05) operant responding at the 5% (t 5 3.9), 10% (t 5 2.7), 20%, (t 5 6.4), and 60% (t 5 9.4) N 2 O concentrations (Fig. 5, lower  panel, m) . Pretreatment with a lower dose of 500 mg/kg ethanol only enhanced (t 5 2.4, P , 0.05) the operant response rate suppressing effects of 60% N 2 O. (Fig. 5, lower  panel, j) .
Discussion
The overarching goal of the present study was to explore the receptor mechanisms underlying the discriminative stimulus effects of N 2 O. Given the strong in vitro evidence that N 2 O attenuates NMDA receptor function (Jevtovi c-Todovori c et al., 1998; Mennerick et al., 1998; Yamakura and Harris, 2000; Balon et al., 2003; Nagele et al., 2004; Sato et al., 2005; Ogata et al., 2006; Petrenko et al., 2010) , a number of site-selective NMDA antagonists were tested for their ability to substitute for N 2 O (Fig. 2) . Neither the competitive NMDA antagonist CGS-19755 nor the NMDA receptor glycine site antagonist L-710,324 produced appreciable substitution for N 2 O. However, doses up to 30 mg/kg of L-701,324 also failed to suppress operant responding. It is therefore possible that an adequate dose range of L-701,324 was not tested, but this seems unlikely given a report showing that 10 mg/kg of L-701,324 has behavioral effects in other rodent discrimination procedures (Nicholson and Balster, 2009 ) and doses lower than 10 mg/kg have other behavioral effects in rodents Wlaz and Poleszak, 2011) . In contrast, the high-affinity NMDA receptor channel blocker (1)-MK-801 produced 55% N 2 O-lever responding, suggesting a possible channel blocker-like effect of N 2 O.
To systematically replicate this finding, we also tested the low-affinity NMDA receptor channel blocker memantine, which produced a comparable level of 50% N 2 O-lever responding. The latter result not only confirmed the findings with (1)-MK-801 but also suggests that the relative affinity of NMDA receptor channel blockers is not critical for modulating N 2 O-like stimulus effects.
Although the data with (1)-MK-801 and memantine suggest that N 2 O may have channel blocker-like stimulus effects, the degree of substitution produced by both drugs was incomplete and could be due to drug effects unrelated to their subjective stimulus properties. For instance, NMDA antagonists disrupt glutamatergic neurotransmission in long-term potentiation (Manahan-Vaughan et al., 2008) , which can interrupt memory recall (Florian and Roullet, 2004) . A disruption of stimulus control could potentially result in levels of N 2 O-lever selection in the range of 50%, which is that which would be expected if the animals were responding randomly on both levers. However, (1)-MK-801 (Sanger and Zivkovic, 1989; Shelton and Balster, 2004) and other channel blockers (Bowen et al., 1999; Beardsley et al., 2002; Balster, 2003, 2009 ) are easily trained in drug-discrimination procedures. Further, if a simple disruption of performance were responsible for the present data, one might have also expected partial substitution with the competitive NMDA antagonist CGS-19755 rather than a complete failure of GCS-19755 to substitute for N 2 O. A more plausible alternative explanation for the partial substitution produced by (1)-MK-801 and memantine is insufficient specificity of the drug-discrimination assay. This hypothesis is based on data showing that under some conditions NMDA channel blockers will generate intermediate levels of substitution in rodents trained to discriminate stimulants, central nervous system depressants, and serotonergics (Koek et al., 1995) . The converse is also true in that benzodiazepines have been demonstrated to produce partial substitution in mice trained to discriminate (1)-MK-801 from vehicle (Shelton and Balster, 2004) . To address whether the partial substitution produced by (1)-MK-801 was due to nonspecific effects, we examined whether pretreatment with (1)-MK-801 at doses that produced little or no substitution for N 2 O when administered alone would alter the discriminative stimulus properties of N 2 O (Fig. 3) . Our hypothesis was that low doses of (1)-MK-801 would only enhance the stimulus effects of N 2 O if they were acting through a similar mechanism. Indeed, if (1)-MK-801 simply disordered behavior, it might be expected to produce a net antagonism of N 2 O's stimulus effects at the higher N 2 O test concentrations. The results showing that (1)-MK-801 produced an orderly and significant enhancement of the discriminative stimulus effects of N 2 O support our hypothesis that the discriminative stimulus effects of N 2 O has a NMDA channel blocker-like component.
Because NMDA antagonists produced incomplete substitution for the training condition, it seems likely that another mechanism also contributes to the stimulus effects of N 2 O. To examine a potential GABAergic contribution to the stimulus effects of N 2 O, five site-selective GABA-positive drugs were tested for their ability to substitute for N 2 O (Table 1) . Of the potential GABAergic mechanisms that might have played a role in the stimulus effects of N 2 O, positive allosteric modulation was most strongly implicated in the literature Zacny et al., 1995; Hapfelmeier et al., 2000) . However, neither the classic benzodiazepine-site positive allosteric modulator midazolam nor the barbiturate pentobarbital produced meaningful levels of substitution for N 2 O. Further, midazolam pretreatment failed to significantly enhance the discriminative stimulus effects of N 2 O, instead producing a trend toward diminishing the discriminative stimulus effects of N 2 O (Fig. 4) . Likewise, neither the extrasynaptic GABA A receptor agonist gaboxadol nor the synaptic GABA A agonist muscimol were N 2 Olike. Lastly, the relatively nonselective GABA transaminase inhibitor valproic acid produced a low level of partial substitution for N 2 O, but only at doses that completely suppressed operant responding in four of eight test subjects.
Opioid receptors have been suggested to be involved in the analgesic and antinociceptive effects of N 2 O (Emmanouil et al., 2008) . However, m-, k-, and d-opioid receptors agonists all failed to produce greater than vehicle appropriate responding in N 2 O-trained mice ( Table 2 ). The poor substitution produced by m-opioid agonist morphine is consistent with data showing that the opioid antagonist naloxone does not attenuate the subjective effects of 30% N 2 O in humans (Zacny et al., 1994 (Zacny et al., , 1999 . Likewise, the failure of the d-opioid agonist SNC-80 to substitute for N 2 O is consistent with reports that the d-opioid receptor agonist naltrindole does not attenuate N 2 O analgesia (Koyama and Fukuda, 2010) . Our data showing that the selective k-opioid agonist U50-488H does not substitute for N 2 O is, however, in conflict with a previous study in which N 2 O generalized to the purported k-opioid agonist ethylketocyclazocine in guinea pigs trained to discriminate ethylketocyclazocine from vehicle (Hynes and Hymson, 1984) . More recent data have suggested that ethylketocyclazocine is a mixed m-/k-opioid agonist and that some of the discriminative stimulus effects of ethylketocyclazocine may result from m-opioid receptor actions (Wessinger et al., 2011) ; however, this does not entirely reconcile the prior finding with our present data. It is possible that the differences between studies were the result of species or methods. Additional work will be necessary to resolve this conflict, but based on our present data it does not appear that N 2 O has opioid-like discriminative stimulus properties under our training conditions.
A number of studies suggest a relationship between the behavioral effect of N 2 O and ethanol. For instance, N 2 O reduces 10% ethanol consumption in alcohol-preferring and heavy-drinking strains of rats (Kosobud et al., 2006) . Although alcohol drinking before N 2 O exposure does not appear to augment the subjective effects of N 2 O (Walker and Zacny, 2001) , N 2 O is chosen more frequently by moderate alcohol drinkers than light drinkers (Zacny et al., 2008) . Most recently, our laboratory reported that ethanol produces partial substitution in mice trained to discriminate N 2 O from vehicle (Richardson and Shelton, 2014) . In our present study, we systematically replicated and expanded our prior results by demonstrating not only that ethanol partially substitutes for N 2 O but also that, like NMDA channel blockers, ethanol pretreatment robustly and significantly facilitates the discriminative stimulus effects of N 2 O (Fig. 5) .
The discriminative stimulus effects of ethanol have been repeatedly demonstrated to be based upon a combination of GABA A positive modulation, NMDA antagonism, and 5-HT 1B/2C agonism (Grant et al., 1997) , any one of which alone is sufficient to elicit ethanol-like stimulus effects. As we had already determined the degree of NMDA and GABAergic involvement in the stimulus effects of N 2 O, we examined both the 5-HT 1B/2C agonist mCPP, which has ethanol-like effects in drug discrimination, as well as the 5-HT 1A agonist 8-OH DPAT. Neither mCPP nor 8-OH-DPAT produced N 2 O-like stimulus effects (Table 2) . Overall, these findings suggest that the ethanol-like discriminative stimulus effects of N 2 O are probably mediated exclusively through a common NMDA channel blocker-like cue component (Grant and Colombo, 1993; Shelton and Grant, 2002; Vivian et al., 2002) .
In summary, our results probe the most probable receptor mechanisms underlying the discriminative stimulus effects of N 2 O. Of these mechanisms, the only class of drugs that engendered meaningful levels of N 2 O-appropriate responding were NMDA receptor channel blockers. However, even the channel blockers failed to elicit full substitution, suggesting that other mechanisms are also involved in transducing the stimulus effects of N 2 O. Several additional candidate mechanisms have been suggested by the literature, including 5-HT 3 antagonism (Yamakura and Harris, 2000; Suzuki et al., 2002) , neuronal nicotinic acetylcholine inhibition (Yamakura and Harris, 2000; Suzuki et al., 2003) , interactions with neuronal nitric oxide synthase enzymes (for a review, see Emmanouil and Quock, 2007) , or TREK-1 potassium channel activation (Gruss et al., 2004) . Additional research examining these mechanisms will be required to fully characterize the discriminative stimulus properties of N 2 O.
